A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Completed · Phase 3

Conditions studied: Breast Neoplasms

In brief

The treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.

Key facts

Study ID

NCT00435409

Run by

Pfizer

People needed

442

Starts

2007-02-01

Expected to finish

2011-06-01

Last updated by the study team

2012-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Locally advanced or metastatic disease that can be measured. Patients with bone-only disease are also allowed to enter the study.
• Previous treatment with an anthracycline and a taxane in any setting
• Progression on first or second line regimen or adjuvant regimen if disease free interval less than 12 months

You may not qualify if…

• History of inflammatory carcinoma if there is no other measurable disease
• More than 2 chemotherapy agents in the advanced disease setting
• Brain metastases

Where it is running

• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Montebello, California, United States
• Pfizer Investigational Site — Whittier, California, United States
• Pfizer Investigational Site — Boca Raton, Florida, United States
• Pfizer Investigational Site — Boynton Beach, Florida, United States
• Pfizer Investigational Site — Coral Springs, Florida, United States
• Pfizer Investigational Site — Hollywood, Florida, United States
• Pfizer Investigational Site — Lake Worth, Florida, United States
• Pfizer Investigational Site — Lakeland, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Pembroke Pines, Florida, United States
• Pfizer Investigational Site — Duluth, Georgia, United States
• Pfizer Investigational Site — Lawrenceville, Georgia, United States
• Pfizer Investigational Site — Snellville, Georgia, United States
• Pfizer Investigational Site — Avon, Indiana, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Mooresville, Indiana, United States
• Pfizer Investigational Site — Covington, Louisiana, United States
• Pfizer Investigational Site — Gretna, Louisiana, United States
• Pfizer Investigational Site — Marrero, Louisiana, United States
• Pfizer Investigational Site — Metairie, Louisiana, United States
• Pfizer Investigational Site — Metairie, Louisiana, United States
• Pfizer Investigational Site — Downey, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.